Trade Mark Journal No.2026/045 6 November 2026

WO0000001944941 (1,5,42)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:3 July 2026
Date of designation in the UK: 3 July 2026
Image for mark 1944941

The mark contains the colours purple, orange and gray

International priority date claimed: 7 January 2026 (European Union Intellectual Property Office (EUIPO)) (019300110)
Class 1
Diagnostic products for scientific use; reagents for medical research; Reagents for medical research in the field of infectious diseases and diseases caused by bacteria; diagnostic reagents for scientific use or for research; Enzymes for scientific use; diagnostic kits for scientific use comprising specimen receptacles and reagents for analyzing selected bacteria.
Class 5
Pharmaceutical products for infectious disease treatment; pharmaceutical products for treatment of diseases caused by bacteria; Antibacterial pharmaceutical products; antibiotics; Biopharmaceuticals for infectious disease treatment; immunotherapeutic agents for bacterial infections; Enzyme preparations for medical use; enzymes for medical use; Enzymes and enzyme preparations for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria.
Class 42
Biomedical research services; scientific research for medical purposes in the field of infectious diseases and diseases caused by bacteria; Research and development of pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; research and development of immunotherapeutic agents for bacterial infections; Research and development of enzymes, enzyme preparations and synthetic proteins for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; clinical trials for pharmaceutical products, antibiotics, tests, biomarkers and reagents for diagnosis, prognosis and treatment of infectious diseases and diseases caused by bacteria; Software as a Service [SaaS]; Platform as a Service [PaaS]; Artificial Intelligence as a Service [AIaaS].

TELUM THERAPEUTICS S.L.

Representative: ZBM PATENTS, Rambla Catalunya, 123, E-08008 Barcelona, SPAIN